JACK HENRY & ASSOCIATES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that JACK HENRY & ASSOCIATES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $417.23M | Aug 24, 2018 |
| FY2018 | Mar 31, 2018 | $384.68M | Aug 24, 2018 |
| FY2018 | Dec 31, 2017 | $374.76M | Aug 24, 2018 |
| FY2018 | Sep 30, 2017 | $359.93M | Aug 24, 2018 |
| FY2018 | Jun 30, 2017 | $383.77M | Aug 24, 2018 |
| FY2018 | Mar 31, 2017 | $353.77M | Aug 24, 2018 |
| FY2018 | Dec 31, 2016 | $348.55M | Aug 24, 2018 |
| FY2018 | Sep 30, 2016 | $345.03M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $366.97M | Aug 25, 2017 |
| FY2017 | Mar 31, 2016 | $333.19M | Aug 25, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.38B | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $2.22B | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $2.08B | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $1.94B | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | $1.76B | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $410.54M | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | $429.41M | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | $419.12M | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | $438.01M | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | $393.51M | Aug 25, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $164.37M | Aug 25, 2017 |
| FY2017 | Mar 31, 2017 | $147.04M | Aug 25, 2017 |
| FY2017 | Dec 31, 2016 | $150.41M | Aug 25, 2017 |
| FY2017 | Sep 30, 2016 | $150.27M | Aug 25, 2017 |
| FY2017 | Jun 30, 2016 | $161.70M | Aug 25, 2017 |
| FY2017 | Mar 31, 2016 | $138.91M | Aug 25, 2017 |
| FY2017 | Dec 31, 2015 | $142.43M | Aug 25, 2017 |
| FY2017 | Sep 30, 2015 | $137.96M | Aug 25, 2017 |
| FY2016 | Jun 30, 2015 | $146.41M | Aug 29, 2016 |
| FY2016 | Mar 31, 2015 | $131.82M | Aug 29, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $455.75M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $381.82M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $366.65M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $362.92M | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | $311.47M | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $61.35M | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | $73.86M | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | $72.10M | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | $89.37M | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | $60.99M | Aug 25, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $568.72M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $489.39M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $480.69M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $474.62M | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | $398.72M | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $76.80M | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | $91.94M | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | $93.70M | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | $118.19M | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | $79.42M | Aug 25, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $162.77M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $148.26M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $142.68M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $121.36M | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | $109.05M | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $29.90M | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | $28.31M | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | $27.19M | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | $24.59M | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | $24.92M | Aug 25, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $283.06M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $278.42M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $235.27M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $218.30M | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | $187.06M | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $49.00M | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | $50.59M | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | $48.96M | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | $49.44M | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | $49.13M | Aug 25, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $641.50M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $568.04M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $381.56M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $504.63M | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | $462.13M | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $510.53M | Aug 25, 2022 |
| FY2021 | Jun 30, 2019 | $431.13M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $412.14M | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | $357.32M | Aug 26, 2019 |
| FY2018 | Jun 30, 2016 | $366.42M | Aug 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $53.36M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $58.12M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $39.18M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $34.66M | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | $22.99M | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $53.54M | Aug 25, 2022 |
| FY2021 | Jun 30, 2019 | $53.60M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $40.14M | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | $41.95M | Aug 26, 2019 |
| FY2018 | Jun 30, 2016 | $56.33M | Aug 24, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.04B | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $2.92B | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $2.77B | Aug 26, 2024 |
| FY2023 | Jun 30, 2022 | $2.46B | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $2.34B | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | $2.43B | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $2.18B | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $2.03B | Aug 26, 2019 |
| FY2018 | Jun 30, 2017 | $1.91B | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $1.82B | Aug 25, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $913.14M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $1.08B | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $1.17B | Aug 26, 2024 |
| FY2023 | Jun 30, 2022 | $1.07B | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $1.02B | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | $878.79M | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $755.82M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $710.21M | Aug 26, 2019 |
| FY2018 | Jun 30, 2017 | $876.89M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $819.30M | Aug 25, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.13B | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $1.84B | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $1.61B | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $1.38B | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | $1.32B | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $1.55B | Aug 25, 2022 |
| FY2021 | Jun 30, 2019 | $1.43B | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $1.32B | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | $1.10B | Aug 26, 2019 |
| FY2018 | Jun 30, 2016 | $996.21M | Aug 24, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $804.80M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $804.80M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $804.80M | Aug 26, 2024 |
| FY2023 | Jun 30, 2022 | $687.46M | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $687.46M | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | $686.33M | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $666.94M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $649.93M | Aug 26, 2019 |
| FY2018 | Jun 30, 2017 | $552.47M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $552.85M | Aug 25, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.37B | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $3.08B | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $2.86B | Aug 26, 2024 |
| FY2023 | Jun 30, 2022 | $2.64B | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $2.41B | Aug 25, 2022 |
| FY2021 | Jun 30, 2020 | $2.24B | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $2.07B | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $1.91B | Aug 26, 2019 |
| FY2018 | Jun 30, 2017 | $1.59B | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $1.43B | Aug 25, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jun 30, 2021 | $50.99M | Aug 25, 2021 |
| FY2021 | Jun 30, 2020 | $213.35M | Aug 25, 2021 |
| FY2021 | Jun 30, 2019 | $93.63M | Aug 25, 2021 |
| FY2021 | Jun 30, 2018 | $31.44M | Aug 25, 2021 |
| FY2020 | Jun 30, 2017 | $114.77M | Aug 25, 2020 |
| FY2019 | Jun 30, 2016 | $70.31M | Aug 26, 2019 |
| FY2018 | Jun 30, 2015 | $148.31M | Aug 24, 2018 |
| FY2017 | Jun 30, 2014 | $70.38M | Aug 25, 2017 |
| FY2016 | Jun 30, 2013 | $127.91M | Aug 29, 2016 |
| FY2015 | Jun 30, 2012 | $157.31M | Sep 11, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $0 | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $60.00M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $275.00M | Aug 26, 2024 |
| FY2023 | Jun 30, 2022 | $115.00M | Aug 24, 2023 |
| FY2019 | Jun 30, 2019 | $0 | Aug 26, 2019 |
| FY2019 | Jun 30, 2018 | $0 | Aug 26, 2019 |
| FY2015 | Jun 30, 2015 | $50.82M | Sep 11, 2015 |
| FY2015 | Jun 30, 2014 | $7.76M | Sep 11, 2015 |
| FY2014 | Jun 30, 2013 | $14.28M | Jun 25, 2015 |
| FY2013 | Jun 30, 2012 | $131.46M | Aug 27, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 6 | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | 5 | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | 5 | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | 4 | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | 4 | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | 1 | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 25, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 6 | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | 5 | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | 5 | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | 4 | Aug 26, 2024 |
| FY2023 | Jun 30, 2021 | 4 | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 25, 2020 |
| FY2020 | Sep 30, 2019 | 1 | Aug 25, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 25, 2020 |